Skip to content Skip to navigation

Physicians Who e-Prescribe Choose Cheaper Drugs, Report Says

March 15, 2013
by Rajiv Leventhal
| Reprints

Surveyed U.S. endocrinologists and primary care physicians (PCPs) said they use e-prescribing for 76 percent of their Medicare patients and 79 percent of their non-Medicare patients, figures that are expected to grow in the next year, according to a report from research and advisory firm Decision Resources. The report, which surveyed 70 endocrinologists and 70 PCPs as well as 25 managed-care organization (MCO) pharmacy directors also found that approximately 80 percent of PCPs and endocrinologists say they would prescribe a less expensive DPP-IV inhibitor to their patients with Type 2 diabetes or hypertension, reflecting high cost-sensitivity.

The report, “E-Prescribing and Electronic Health Records: Impact of Technology on Prescribing for Hypertension and Diabetes,” said that 84 percent of MCO pharmacy directors have seen physicians prescribing drugs with lower patient costs and fewer restrictions because of the information provided in e-prescribing solutions.

Within their e-prescribing program, roughly 60 percent of physicians say they have access to their patients' formularies. These physicians report they have easy access to formularies for most of their patients and that this knowledge results in them paying more attention to patient costs.

According to the findings, e-prescribing and electronic health records (EHRs) represent a challenge to marketers of branded drugs. Providing physicians access to formulary information, including copay amounts, is leading these physicians to prescribe the best-reimbursed drug. As a result, formulary placement takes on greater importance.

"The vast majority of physicians say their electronic health record systems only have patient information from their own physician group, meaning they have incomplete information on their patients—this lack of shared information represents a shortcoming of current EHR adoption and prevents improved patient management," Decision Resources Product Manager Roy Moore, said in a statement . "The ability of EHRs to aggregate data and allow for population health management—an underutilized feature today—will allow marketers of branded therapies to demonstrate the superiority of their products versus other competitors and generics. Physician and MCO desires to reduce costs and hospitalizations should make them receptive to clinical data showing therapies' effectiveness along these metrics."



CMS Hospital Compare Website Updated with VA Data

The Centers for Medicare & Medicaid Services (CMS) has announced the inclusion of Veterans Administration (VA) hospital performance data as part of the federal agency’s Hospital Compare website.

CMS Awards Funding to Special Innovation Projects

The Centers for Medicare & Medicaid Services (CMS) has awarded 20, two-year Special Innovation Projects (SIPs) aimed at local efforts to deliver better care at lower cost.

Center of Excellence in Genomic Science to be Established in Chicago

The National Human Genome Research Institute has awarded $10.6 million over five years for the establishment of a new research center in Chicago to advance genomic science.

EHNAC and HITRUST Combine HIPAA Security Criteria, CSF Framework

The Electronic Healthcare Network Accreditation Commission (EHNAC) and the Health Information Trust Alliance (HITRUST) announced plans to streamline their accreditation and certification programs.

Halamka on MACRA Final Rule: “CMS is Listening and I Thank Them”

Health IT notable expert John Halamka, M.D., CIO of Beth Israel Deaconess Medical Center in Boston, recently weighed in on the Medicare Access and CHIP Reauthorization Act (MACRA) final rule.

Texas Patient Care Clinic Hit with Ransomware Attack

Grand Prairie, Texas-based Rainbow Children's Clinic was the victim of a ransomware attack on its IT systems in August, affecting more than 33,000 patients, according to multiple news media reports this week.